Search clinical trials for: Sodium-Glucose Transporter 2 Inhibitors
Total 16040 results
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, Taiwan, China, Mexico, Germany, Poland
-
Central Hospital, Nancy, FranceNot yet recruiting
-
October 6 UniversityCairo University; National Heart Institute, EgyptRecruitingDiabetes Mellitus | Chronic Heart Failure | Acute Heart FailureEgypt
-
Frank RuschitzkaAstraZenecaRecruiting
-
University of Sao PauloCompletedDiabetes Mellitus, Type 2 | Coronary Heart Disease | Arrythmia, CardiacBrazil
-
Boehringer IngelheimEli Lilly and CompanyActive, not recruiting
-
Albert Einstein Healthcare NetworkSuspendedAcute Kidney Injury | Percutaneous Coronary InterventionUnited States
-
Vanderbilt University Medical CenterCompletedObesity | Pre-diabetesUnited States
-
AstraZenecaCompletedChronic Kidney DiseaseUnited States, Italy, Spain, Brazil, Malaysia, Australia, South Africa, Hungary, Georgia, Japan, Bulgaria, Poland, Ukraine, Denmark, Argentina, Slovakia, Canada, Croatia, Netherlands
-
Insel Gruppe AG, University Hospital BernCompleted
-
Novo Nordisk A/SCompletedHealthy VolunteersGermany
-
Stanford UniversityCompletedLiver Cirrhosis | Cirrhosis | Ascites | Ascites Hepatic | Sodium-Glucose Transporter 2 InhibitorsUnited States
-
Steno Diabetes Center CopenhagenUniversity of CopenhagenCompletedType 2 Diabetes | Maturity-Onset Diabetes of the Young, Type 3Denmark
-
University Hospital Inselspital, BerneCompletedDiabetes Mellitus, Type 1Switzerland
-
University of Campinas, BrazilCompletedEnd-stage Renal DiseaseBrazil
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedPancreatic Cancer | Pancreas Cancer | Cancer of the PancreasUnited States
-
Zhijun SunEnrolling by invitationHeart Failure | Heart Failure With Preserved Ejection FractionChina
-
Region SkaneGöteborg UniversityActive, not recruitingType2 DiabetesSweden
-
University Hospital, Basel, SwitzerlandCompletedHyponatremia | SIAD - Syndrome of Inappropriate AntidiuresisSwitzerland
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
MajianhuaCompletedType 2 DiabetesChina
-
Hua Medicine LimitedCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States, Austria, Germany, Italy, Spain, United Kingdom, Belgium, Mexico, Israel, Hungary, Canada, Australia, Denmark, Sweden, Romania, France, Finland
-
Merck Sharp & Dohme LLCPfizerCompletedType 2 Diabetes Mellitus | Hepatic Impairment
-
AstraZenecaBristol-Myers SquibbCompleted
-
Janssen Scientific Affairs, LLCCompletedHypertension | Diabetes Mellitus, Type 2United States, Puerto Rico
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States
-
AstraZenecaBristol-Myers SquibbCompletedDiabetes Mellitus, Type 2Australia, United States, Italy, Argentina, Canada, Mexico, India, Peru, Spain, Denmark, France, Singapore, Puerto Rico
-
AstraZenecaBristol-Myers SquibbCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHepatic Insufficiency | HealthyRomania
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2Korea, Republic of, United States, Germany
-
Astellas Pharma IncCompletedA Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941Healthy | Pharmacokinetics of ASP1941Japan
-
Nanjing University School of MedicineRecruiting
-
Shahid Beheshti University of Medical SciencesRecruitingHeart Failure | HemodialysisIran, Islamic Republic of
-
Dong-A ST Co., Ltd.Recruiting
-
Monaldi HospitalRecruitingEfficacy | Systemic Right Ventricle | Dapagliflozin Adverse ReactionItaly
-
University of MilanNot yet recruiting
-
G.Gennimatas General Hospital2nd Department of Cardiology, "Attikon" University Hospital, National and...Not yet recruitingAcute Kidney Injury | Percutaneous Coronary Intervention | Left Cardiac Catheterization | Sodium-glucose Co-transporter 2 InhibitorsGreece
-
University of VirginiaNational Heart, Lung, and Blood Institute (NHLBI)RecruitingType2 Diabetes | Insulin SensitivityUnited States
-
Spanish Society of CardiologyFundación Centro Nacional de Investigaciones Cardiovasculares Carlos IIIActive, not recruitingAortic Stenosis | Transcatether Aortic Valve ImplantationSpain
-
Boehringer IngelheimActive, not recruitingHeart FailureCzechia, Switzerland, Poland, Hungary, Romania, Bulgaria
-
University of WashingtonAstraZenecaCompletedMyocardial Fibrosis | Type 2 Diabetes Mellitus | Myocardial InflammationUnited States
-
Hospices Civils de LyonWithdrawnEnd-stage Heart FailureFrance
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Denmark, Canada, Belgium, China, Italy, Germany, Spain, Netherlands, Hungary, Japan, Norway, Poland, Sweden, Czechia
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
Boehringer IngelheimCompleted
-
Novartis PharmaceuticalsCompleted
-
Yale UniversityBoehringer IngelheimCompletedHeart Failure | Type II; DiabetesUnited States
-
Astellas Pharma IncCompleted